 | • レポートコード：QYR2104Z5021 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、網膜血管閉塞のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗血管内皮増殖因子（VEGF）、副腎皮質ステロイド、抗凝血性、線維素溶解性、その他）、用途別市場規模（病院・診療所、研究・学術、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・網膜血管閉塞の市場動向 ・企業の競争状況、市場シェア ・網膜血管閉塞の種類別市場規模（抗血管内皮増殖因子（VEGF）、副腎皮質ステロイド、抗凝血性、線維素溶解性、その他） ・網膜血管閉塞の用途別市場規模（病院・診療所、研究・学術、その他） ・網膜血管閉塞の北米市場規模2016-2027（アメリカ、カナダ） ・網膜血管閉塞のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・網膜血管閉塞のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・網膜血管閉塞の中南米市場規模2016-2027（メキシコ、ブラジル） ・網膜血管閉塞の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Regeneron Pharmaceuticals, Inc.、Bayer HealthCare Pharmaceuticals LLC.、Novartis AG、Pfizer, Inc.、AstraZeneca PLC.、GlaxoSmithKline PLC.、Johnson & Johnson、Teva pharmaceutical industries、Novo Nordisk、Sanofi） ・結論 |
Retinal Vascular Occlusion (RVO) is the build-up of blood or other fluids in the retina of the eye, which prevents it from properly filtering light caused by the blood clot.
The Americas account for a significant market share owing to high expenditure on the health care, especially, of the U.S. and Canada. Additionally, the greater number of ophthalmology procedures due to greater healthcare penetration in the U.S. and Canada drives the retinal vascular occlusion market. The high concentration of the major hospitals in the developed countries of this region coupled with good reimbursement rates is adding fuel to the market growth. Moreover, the large share of ophthalmology procedures, especially, the retinal vascular occlusion surgery treatment in the returns of hospitals favors the market. The large number of pharmaceutical companies in the U.S. is also a cause for the faster development of retinal vascular occlusion market in the US. The high development of the microsurgery field in developed regions such as the U.S. and Europe is a strong driver of the market.
Market Analysis and Insights: Global Retinal Vascular Occlusion Market
The global Retinal Vascular Occlusion market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Retinal Vascular Occlusion market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Retinal Vascular Occlusion market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Retinal Vascular Occlusion market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Retinal Vascular Occlusion market.
Global Retinal Vascular Occlusion Scope and Market Size
Retinal Vascular Occlusion market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Retinal Vascular Occlusion market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Anti-vascular Endothelial Growth Factor (VEGF)
Corticosteroid
Anticoagulants
Fibrinolytic
Others
Segment by Application
Hospitals and Clinics
Research and Academics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Regeneron Pharmaceuticals, Inc.
Bayer HealthCare Pharmaceuticals LLC.
Novartis AG
Pfizer, Inc.
AstraZeneca PLC.
GlaxoSmithKline PLC.
Johnson & Johnson
Teva pharmaceutical industries
Novo Nordisk
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinal Vascular Occlusion Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anti-vascular Endothelial Growth Factor (VEGF)
1.2.3 Corticosteroid
1.2.4 Anticoagulants
1.2.5 Fibrinolytic
1.2.6 Others
1.3 Market by Application
1.3.1 Global Retinal Vascular Occlusion Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals and Clinics
1.3.3 Research and Academics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Retinal Vascular Occlusion Market Perspective (2016-2027)
2.2 Retinal Vascular Occlusion Growth Trends by Regions
2.2.1 Retinal Vascular Occlusion Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Retinal Vascular Occlusion Historic Market Share by Regions (2016-2021)
2.2.3 Retinal Vascular Occlusion Forecasted Market Size by Regions (2022-2027)
2.3 Retinal Vascular Occlusion Industry Dynamic
2.3.1 Retinal Vascular Occlusion Market Trends
2.3.2 Retinal Vascular Occlusion Market Drivers
2.3.3 Retinal Vascular Occlusion Market Challenges
2.3.4 Retinal Vascular Occlusion Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Retinal Vascular Occlusion Players by Revenue
3.1.1 Global Top Retinal Vascular Occlusion Players by Revenue (2016-2021)
3.1.2 Global Retinal Vascular Occlusion Revenue Market Share by Players (2016-2021)
3.2 Global Retinal Vascular Occlusion Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Retinal Vascular Occlusion Revenue
3.4 Global Retinal Vascular Occlusion Market Concentration Ratio
3.4.1 Global Retinal Vascular Occlusion Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinal Vascular Occlusion Revenue in 2020
3.5 Retinal Vascular Occlusion Key Players Head office and Area Served
3.6 Key Players Retinal Vascular Occlusion Product Solution and Service
3.7 Date of Enter into Retinal Vascular Occlusion Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Retinal Vascular Occlusion Breakdown Data by Type
4.1 Global Retinal Vascular Occlusion Historic Market Size by Type (2016-2021)
4.2 Global Retinal Vascular Occlusion Forecasted Market Size by Type (2022-2027)
5 Retinal Vascular Occlusion Breakdown Data by Application
5.1 Global Retinal Vascular Occlusion Historic Market Size by Application (2016-2021)
5.2 Global Retinal Vascular Occlusion Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Retinal Vascular Occlusion Market Size (2016-2027)
6.2 North America Retinal Vascular Occlusion Market Size by Type
6.2.1 North America Retinal Vascular Occlusion Market Size by Type (2016-2021)
6.2.2 North America Retinal Vascular Occlusion Market Size by Type (2022-2027)
6.2.3 North America Retinal Vascular Occlusion Market Size by Type (2016-2027)
6.3 North America Retinal Vascular Occlusion Market Size by Application
6.3.1 North America Retinal Vascular Occlusion Market Size by Application (2016-2021)
6.3.2 North America Retinal Vascular Occlusion Market Size by Application (2022-2027)
6.3.3 North America Retinal Vascular Occlusion Market Size by Application (2016-2027)
6.4 North America Retinal Vascular Occlusion Market Size by Country
6.4.1 North America Retinal Vascular Occlusion Market Size by Country (2016-2021)
6.4.2 North America Retinal Vascular Occlusion Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Retinal Vascular Occlusion Market Size (2016-2027)
7.2 Europe Retinal Vascular Occlusion Market Size by Type
7.2.1 Europe Retinal Vascular Occlusion Market Size by Type (2016-2021)
7.2.2 Europe Retinal Vascular Occlusion Market Size by Type (2022-2027)
7.2.3 Europe Retinal Vascular Occlusion Market Size by Type (2016-2027)
7.3 Europe Retinal Vascular Occlusion Market Size by Application
7.3.1 Europe Retinal Vascular Occlusion Market Size by Application (2016-2021)
7.3.2 Europe Retinal Vascular Occlusion Market Size by Application (2022-2027)
7.3.3 Europe Retinal Vascular Occlusion Market Size by Application (2016-2027)
7.4 Europe Retinal Vascular Occlusion Market Size by Country
7.4.1 Europe Retinal Vascular Occlusion Market Size by Country (2016-2021)
7.4.2 Europe Retinal Vascular Occlusion Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Retinal Vascular Occlusion Market Size (2016-2027)
8.2 Asia-Pacific Retinal Vascular Occlusion Market Size by Type
8.2.1 Asia-Pacific Retinal Vascular Occlusion Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Retinal Vascular Occlusion Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Retinal Vascular Occlusion Market Size by Type (2016-2027)
8.3 Asia-Pacific Retinal Vascular Occlusion Market Size by Application
8.3.1 Asia-Pacific Retinal Vascular Occlusion Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Retinal Vascular Occlusion Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Retinal Vascular Occlusion Market Size by Application (2016-2027)
8.4 Asia-Pacific Retinal Vascular Occlusion Market Size by Region
8.4.1 Asia-Pacific Retinal Vascular Occlusion Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Retinal Vascular Occlusion Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Retinal Vascular Occlusion Market Size (2016-2027)
9.2 Latin America Retinal Vascular Occlusion Market Size by Type
9.2.1 Latin America Retinal Vascular Occlusion Market Size by Type (2016-2021)
9.2.2 Latin America Retinal Vascular Occlusion Market Size by Type (2022-2027)
9.2.3 Latin America Retinal Vascular Occlusion Market Size by Type (2016-2027)
9.3 Latin America Retinal Vascular Occlusion Market Size by Application
9.3.1 Latin America Retinal Vascular Occlusion Market Size by Application (2016-2021)
9.3.2 Latin America Retinal Vascular Occlusion Market Size by Application (2022-2027)
9.3.3 Latin America Retinal Vascular Occlusion Market Size by Application (2016-2027)
9.4 Latin America Retinal Vascular Occlusion Market Size by Country
9.4.1 Latin America Retinal Vascular Occlusion Market Size by Country (2016-2021)
9.4.2 Latin America Retinal Vascular Occlusion Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Retinal Vascular Occlusion Market Size (2016-2027)
10.2 Middle East & Africa Retinal Vascular Occlusion Market Size by Type
10.2.1 Middle East & Africa Retinal Vascular Occlusion Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Retinal Vascular Occlusion Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Retinal Vascular Occlusion Market Size by Type (2016-2027)
10.3 Middle East & Africa Retinal Vascular Occlusion Market Size by Application
10.3.1 Middle East & Africa Retinal Vascular Occlusion Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Retinal Vascular Occlusion Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Retinal Vascular Occlusion Market Size by Application (2016-2027)
10.4 Middle East & Africa Retinal Vascular Occlusion Market Size by Country
10.4.1 Middle East & Africa Retinal Vascular Occlusion Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Retinal Vascular Occlusion Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Regeneron Pharmaceuticals, Inc.
11.1.1 Regeneron Pharmaceuticals, Inc. Company Details
11.1.2 Regeneron Pharmaceuticals, Inc. Business Overview
11.1.3 Regeneron Pharmaceuticals, Inc. Retinal Vascular Occlusion Introduction
11.1.4 Regeneron Pharmaceuticals, Inc. Revenue in Retinal Vascular Occlusion Business (2016-2021)
11.1.5 Regeneron Pharmaceuticals, Inc. Recent Development
11.2 Bayer HealthCare Pharmaceuticals LLC.
11.2.1 Bayer HealthCare Pharmaceuticals LLC. Company Details
11.2.2 Bayer HealthCare Pharmaceuticals LLC. Business Overview
11.2.3 Bayer HealthCare Pharmaceuticals LLC. Retinal Vascular Occlusion Introduction
11.2.4 Bayer HealthCare Pharmaceuticals LLC. Revenue in Retinal Vascular Occlusion Business (2016-2021)
11.2.5 Bayer HealthCare Pharmaceuticals LLC. Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Retinal Vascular Occlusion Introduction
11.3.4 Novartis AG Revenue in Retinal Vascular Occlusion Business (2016-2021)
11.3.5 Novartis AG Recent Development
11.4 Pfizer, Inc.
11.4.1 Pfizer, Inc. Company Details
11.4.2 Pfizer, Inc. Business Overview
11.4.3 Pfizer, Inc. Retinal Vascular Occlusion Introduction
11.4.4 Pfizer, Inc. Revenue in Retinal Vascular Occlusion Business (2016-2021)
11.4.5 Pfizer, Inc. Recent Development
11.5 AstraZeneca PLC.
11.5.1 AstraZeneca PLC. Company Details
11.5.2 AstraZeneca PLC. Business Overview
11.5.3 AstraZeneca PLC. Retinal Vascular Occlusion Introduction
11.5.4 AstraZeneca PLC. Revenue in Retinal Vascular Occlusion Business (2016-2021)
11.5.5 AstraZeneca PLC. Recent Development
11.6 GlaxoSmithKline PLC.
11.6.1 GlaxoSmithKline PLC. Company Details
11.6.2 GlaxoSmithKline PLC. Business Overview
11.6.3 GlaxoSmithKline PLC. Retinal Vascular Occlusion Introduction
11.6.4 GlaxoSmithKline PLC. Revenue in Retinal Vascular Occlusion Business (2016-2021)
11.6.5 GlaxoSmithKline PLC. Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Details
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Retinal Vascular Occlusion Introduction
11.7.4 Johnson & Johnson Revenue in Retinal Vascular Occlusion Business (2016-2021)
11.7.5 Johnson & Johnson Recent Development
11.8 Teva pharmaceutical industries
11.8.1 Teva pharmaceutical industries Company Details
11.8.2 Teva pharmaceutical industries Business Overview
11.8.3 Teva pharmaceutical industries Retinal Vascular Occlusion Introduction
11.8.4 Teva pharmaceutical industries Revenue in Retinal Vascular Occlusion Business (2016-2021)
11.8.5 Teva pharmaceutical industries Recent Development
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Details
11.9.2 Novo Nordisk Business Overview
11.9.3 Novo Nordisk Retinal Vascular Occlusion Introduction
11.9.4 Novo Nordisk Revenue in Retinal Vascular Occlusion Business (2016-2021)
11.9.5 Novo Nordisk Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Retinal Vascular Occlusion Introduction
11.10.4 Sanofi Revenue in Retinal Vascular Occlusion Business (2016-2021)
11.10.5 Sanofi Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Retinal Vascular Occlusion Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anti-vascular Endothelial Growth Factor (VEGF)
Table 3. Key Players of Corticosteroid
Table 4. Key Players of Anticoagulants
Table 5. Key Players of Fibrinolytic
Table 6. Key Players of Others
Table 7. Global Retinal Vascular Occlusion Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Retinal Vascular Occlusion Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Retinal Vascular Occlusion Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Retinal Vascular Occlusion Market Share by Regions (2016-2021)
Table 11. Global Retinal Vascular Occlusion Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Retinal Vascular Occlusion Market Share by Regions (2022-2027)
Table 13. Retinal Vascular Occlusion Market Trends
Table 14. Retinal Vascular Occlusion Market Drivers
Table 15. Retinal Vascular Occlusion Market Challenges
Table 16. Retinal Vascular Occlusion Market Restraints
Table 17. Global Retinal Vascular Occlusion Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Retinal Vascular Occlusion Market Share by Players (2016-2021)
Table 19. Global Top Retinal Vascular Occlusion Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Vascular Occlusion as of 2020)
Table 20. Ranking of Global Top Retinal Vascular Occlusion Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Retinal Vascular Occlusion Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Retinal Vascular Occlusion Product Solution and Service
Table 24. Date of Enter into Retinal Vascular Occlusion Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Retinal Vascular Occlusion Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Retinal Vascular Occlusion Revenue Market Share by Type (2016-2021)
Table 28. Global Retinal Vascular Occlusion Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Retinal Vascular Occlusion Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Retinal Vascular Occlusion Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Retinal Vascular Occlusion Revenue Market Share by Application (2016-2021)
Table 32. Global Retinal Vascular Occlusion Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Retinal Vascular Occlusion Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Retinal Vascular Occlusion Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Retinal Vascular Occlusion Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Retinal Vascular Occlusion Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Retinal Vascular Occlusion Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Retinal Vascular Occlusion Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Retinal Vascular Occlusion Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Retinal Vascular Occlusion Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Retinal Vascular Occlusion Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Retinal Vascular Occlusion Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Retinal Vascular Occlusion Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Retinal Vascular Occlusion Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Retinal Vascular Occlusion Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Retinal Vascular Occlusion Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Retinal Vascular Occlusion Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Retinal Vascular Occlusion Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Retinal Vascular Occlusion Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Retinal Vascular Occlusion Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Retinal Vascular Occlusion Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Retinal Vascular Occlusion Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Retinal Vascular Occlusion Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Retinal Vascular Occlusion Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Retinal Vascular Occlusion Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Retinal Vascular Occlusion Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Retinal Vascular Occlusion Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Retinal Vascular Occlusion Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Retinal Vascular Occlusion Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Retinal Vascular Occlusion Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Retinal Vascular Occlusion Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Retinal Vascular Occlusion Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Retinal Vascular Occlusion Market Size by Country (2022-2027) & (US$ Million)
Table 64. Regeneron Pharmaceuticals, Inc. Company Details
Table 65. Regeneron Pharmaceuticals, Inc. Business Overview
Table 66. Regeneron Pharmaceuticals, Inc. Retinal Vascular Occlusion Product
Table 67. Regeneron Pharmaceuticals, Inc. Revenue in Retinal Vascular Occlusion Business (2016-2021) & (US$ Million)
Table 68. Regeneron Pharmaceuticals, Inc. Recent Development
Table 69. Bayer HealthCare Pharmaceuticals LLC. Company Details
Table 70. Bayer HealthCare Pharmaceuticals LLC. Business Overview
Table 71. Bayer HealthCare Pharmaceuticals LLC. Retinal Vascular Occlusion Product
Table 72. Bayer HealthCare Pharmaceuticals LLC. Revenue in Retinal Vascular Occlusion Business (2016-2021) & (US$ Million)
Table 73. Bayer HealthCare Pharmaceuticals LLC. Recent Development
Table 74. Novartis AG Company Details
Table 75. Novartis AG Business Overview
Table 76. Novartis AG Retinal Vascular Occlusion Product
Table 77. Novartis AG Revenue in Retinal Vascular Occlusion Business (2016-2021) & (US$ Million)
Table 78. Novartis AG Recent Development
Table 79. Pfizer, Inc. Company Details
Table 80. Pfizer, Inc. Business Overview
Table 81. Pfizer, Inc. Retinal Vascular Occlusion Product
Table 82. Pfizer, Inc. Revenue in Retinal Vascular Occlusion Business (2016-2021) & (US$ Million)
Table 83. Pfizer, Inc. Recent Development
Table 84. AstraZeneca PLC. Company Details
Table 85. AstraZeneca PLC. Business Overview
Table 86. AstraZeneca PLC. Retinal Vascular Occlusion Product
Table 87. AstraZeneca PLC. Revenue in Retinal Vascular Occlusion Business (2016-2021) & (US$ Million)
Table 88. AstraZeneca PLC. Recent Development
Table 89. GlaxoSmithKline PLC. Company Details
Table 90. GlaxoSmithKline PLC. Business Overview
Table 91. GlaxoSmithKline PLC. Retinal Vascular Occlusion Product
Table 92. GlaxoSmithKline PLC. Revenue in Retinal Vascular Occlusion Business (2016-2021) & (US$ Million)
Table 93. GlaxoSmithKline PLC. Recent Development
Table 94. Johnson & Johnson Company Details
Table 95. Johnson & Johnson Business Overview
Table 96. Johnson & Johnson Retinal Vascular Occlusion Product
Table 97. Johnson & Johnson Revenue in Retinal Vascular Occlusion Business (2016-2021) & (US$ Million)
Table 98. Johnson & Johnson Recent Development
Table 99. Teva pharmaceutical industries Company Details
Table 100. Teva pharmaceutical industries Business Overview
Table 101. Teva pharmaceutical industries Revenue in Retinal Vascular Occlusion Business (2016-2021) & (US$ Million)
Table 102. Teva pharmaceutical industries Recent Development
Table 103. Novo Nordisk Company Details
Table 104. Novo Nordisk Business Overview
Table 105. Novo Nordisk Retinal Vascular Occlusion Product
Table 106. Novo Nordisk Revenue in Retinal Vascular Occlusion Business (2016-2021) & (US$ Million)
Table 107. Novo Nordisk Recent Development
Table 108. Sanofi Company Details
Table 109. Sanofi Business Overview
Table 110. Sanofi Retinal Vascular Occlusion Product
Table 111. Sanofi Revenue in Retinal Vascular Occlusion Business (2016-2021) & (US$ Million)
Table 112. Sanofi Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinal Vascular Occlusion Market Share by Type: 2020 VS 2027
Figure 2. Anti-vascular Endothelial Growth Factor (VEGF) Features
Figure 3. Corticosteroid Features
Figure 4. Anticoagulants Features
Figure 5. Fibrinolytic Features
Figure 6. Others Features
Figure 7. Global Retinal Vascular Occlusion Market Share by Application: 2020 VS 2027
Figure 8. Hospitals and Clinics Case Studies
Figure 9. Research and Academics Case Studies
Figure 10. Others Case Studies
Figure 11. Retinal Vascular Occlusion Report Years Considered
Figure 12. Global Retinal Vascular Occlusion Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Retinal Vascular Occlusion Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Retinal Vascular Occlusion Market Share by Regions: 2020 VS 2027
Figure 15. Global Retinal Vascular Occlusion Market Share by Regions (2022-2027)
Figure 16. Global Retinal Vascular Occlusion Market Share by Players in 2020
Figure 17. Global Top Retinal Vascular Occlusion Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Vascular Occlusion as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Retinal Vascular Occlusion Revenue in 2020
Figure 19. Global Retinal Vascular Occlusion Revenue Market Share by Type (2016-2021)
Figure 20. Global Retinal Vascular Occlusion Revenue Market Share by Type (2022-2027)
Figure 21. North America Retinal Vascular Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Retinal Vascular Occlusion Market Share by Type (2016-2027)
Figure 23. North America Retinal Vascular Occlusion Market Share by Application (2016-2027)
Figure 24. North America Retinal Vascular Occlusion Market Share by Country (2016-2027)
Figure 25. United States Retinal Vascular Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Retinal Vascular Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Retinal Vascular Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Retinal Vascular Occlusion Market Share by Type (2016-2027)
Figure 29. Europe Retinal Vascular Occlusion Market Share by Application (2016-2027)
Figure 30. Europe Retinal Vascular Occlusion Market Share by Country (2016-2027)
Figure 31. Germany Retinal Vascular Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Retinal Vascular Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Retinal Vascular Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Retinal Vascular Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Retinal Vascular Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Retinal Vascular Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Retinal Vascular Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Retinal Vascular Occlusion Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Retinal Vascular Occlusion Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Retinal Vascular Occlusion Market Share by Region (2016-2027)
Figure 41. China Retinal Vascular Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Retinal Vascular Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Retinal Vascular Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Retinal Vascular Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Retinal Vascular Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Retinal Vascular Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Retinal Vascular Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Retinal Vascular Occlusion Market Share by Type (2016-2027)
Figure 49. Latin America Retinal Vascular Occlusion Market Share by Application (2016-2027)
Figure 50. Latin America Retinal Vascular Occlusion Market Share by Country (2016-2027)
Figure 51. Mexico Retinal Vascular Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Retinal Vascular Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Retinal Vascular Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Retinal Vascular Occlusion Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Retinal Vascular Occlusion Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Retinal Vascular Occlusion Market Share by Country (2016-2027)
Figure 57. Turkey Retinal Vascular Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Retinal Vascular Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Retinal Vascular Occlusion Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Regeneron Pharmaceuticals, Inc. Revenue Growth Rate in Retinal Vascular Occlusion Business (2016-2021)
Figure 61. Bayer HealthCare Pharmaceuticals LLC. Revenue Growth Rate in Retinal Vascular Occlusion Business (2016-2021)
Figure 62. Novartis AG Revenue Growth Rate in Retinal Vascular Occlusion Business (2016-2021)
Figure 63. Pfizer, Inc. Revenue Growth Rate in Retinal Vascular Occlusion Business (2016-2021)
Figure 64. AstraZeneca PLC. Revenue Growth Rate in Retinal Vascular Occlusion Business (2016-2021)
Figure 65. GlaxoSmithKline PLC. Revenue Growth Rate in Retinal Vascular Occlusion Business (2016-2021)
Figure 66. Johnson & Johnson Revenue Growth Rate in Retinal Vascular Occlusion Business (2016-2021)
Figure 67. Teva pharmaceutical industries Revenue Growth Rate in Retinal Vascular Occlusion Business (2016-2021)
Figure 68. Novo Nordisk Revenue Growth Rate in Retinal Vascular Occlusion Business (2016-2021)
Figure 69. Sanofi Revenue Growth Rate in Retinal Vascular Occlusion Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の抗血管内皮増殖因子（抗VEGF）療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti–vascular Endothelial Growth Factor Therapy Market The global Anti–vascular Endothelial Growth Factor Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accu…- 世界の抗血管内皮増殖因子（抗VEGF）療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti–vascular Endothelial Growth Factor Therapy Market The global Anti–vascular Endothelial Growth Factor Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accu…
- 世界の抗血管内皮増殖因子（抗VEGF）薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market The global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…
- 世界の抗血管内皮増殖因子（抗VEGF）薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs Market The global Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…
- 世界の網膜静脈閉塞症治療薬市場規模・現状・予測（2021年-2027年） Retinal vein occlusion (RVO) is a sight-threatening retinal vascular disorder associated with macular edema and neovascularization. The RVO is mainly of two types based on the anatomy of the vein occlusion. The two types are branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CR…